Literature DB >> 19155971

Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.

Mary Hummel1, Sunil M Kurian, Simon Lin, Aleksey Borodyanskiy, Zheng Zhang, Zhigao Li, Soo Jung Kim, Daniel R Salomon, Michael Abecassis.   

Abstract

BACKGROUND: Increased levels of tumor necrosis factor (TNF) are a risk factor for allograft rejection. In vitro studies have shown that binding of TNF to its receptor activates signaling cascades that induce expression of many genes involved in inflammation. The role of intragraft TNF receptor (TNFR) signaling in activation of gene expression in allografts has not been studied.
METHODS: Gene expression profiling and quantitative real-time polymerase chain reaction analysis were used to investigate the role of TNFR signaling in the early intragraft activation of cellular gene expression in renal allografts at 2 days posttransplant.
RESULTS: The TNFRs play a critical role in activating intragraft expression of transcription factors controlling innate and adaptive immunity and stress responses (interferon regulatory factor [IRF]1, IRF 8, Isgf3g, and ATF3) of cytokines and receptors mediating inflammation (TNF, interleukin [IL]-6, interferon-gamma, oncostatin M receptor [OMCR], toll-like receptor [TLR]2, and IL-2Rgamma), of chemokines and adhesion molecules that recruit inflammatory cells (Cxcl9, Cxcl11, E-selectin, and intracellular adhesion molecule [ICAM]-1), of genes involved in costimulation of T cells and processing and presentation of antigens (H2-DMb, Psmb8, and CD40), and genes that mediate the response to interferons. In addition to its proinflammatory role, TNFR signaling induces expression of SOCS3, a negative regulator of IL-6 and OSMR signaling and Nfkbie, and a negative regulator of TNFR signal transduction.
CONCLUSIONS: These studies illustrate the pleiotropic effect of TNF in both activation and down-modulation of the immune response and the complex interactions between the TNFRs and other cytokine signaling pathways in the early allograft response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155971     DOI: 10.1097/TP.0b013e3181938971

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.

Authors:  Zheng Zhang; Longhui Qiu; Shixian Yan; Jiao-Jing Wang; Paul M Thomas; Manoj Kandpal; Lihui Zhao; Andre Iovane; Xue-Feng Liu; Edward B Thorp; Qing Chen; Mary Hummel; Yashpal S Kanwar; Michael M Abecassis
Journal:  Am J Transplant       Date:  2019-05-14       Impact factor: 8.086

2.  Perioperative infliximab application has marginal effects on ischemia-reperfusion injury in experimental small bowel transplantation in rats.

Authors:  T Pech; J Fujishiro; T Finger; I Ohsawa; M Praktiknjo; M von Websky; S Wehner; K Abu-Elmagd; J C Kalff; N Schaefer
Journal:  Langenbecks Arch Surg       Date:  2011-09-30       Impact factor: 3.445

3.  Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.

Authors:  Xue-Feng Liu; Chunfa Jie; Zheng Zhang; Shixian Yan; Jiao-Jing Wang; Xueqiong Wang; Sunil Kurian; Daniel R Salomon; Michael Abecassis; Mary Hummel
Journal:  J Gen Virol       Date:  2016-01-20       Impact factor: 3.891

4.  TNF-alpha signaling is not required for in vivo transcriptional reactivation of latent murine cytomegalovirus.

Authors:  Zheng Zhang; Zhigao Li; Shixian Yan; Xueqiong Wang; Michael Abecassis
Journal:  Transplantation       Date:  2009-09-15       Impact factor: 4.939

5.  Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.

Authors:  Meda E Pavkov; Robert G Nelson; William C Knowler; Yiling Cheng; Andrzej S Krolewski; Monika A Niewczas
Journal:  Kidney Int       Date:  2014-10-01       Impact factor: 10.612

Review 6.  Tumor necrosis factor receptor 2: its contribution to acute cellular rejection and clear cell renal carcinoma.

Authors:  Jun Wang; Rafia S Al-Lamki
Journal:  Biomed Res Int       Date:  2013-11-17       Impact factor: 3.411

7.  MHC universal cells survive in an allogeneic environment after incompatible transplantation.

Authors:  Constança Figueiredo; Dirk Wedekind; Thomas Müller; Stefanie Vahlsing; Peter A Horn; Axel Seltsam; Rainer Blasczyk
Journal:  Biomed Res Int       Date:  2013-10-09       Impact factor: 3.411

Review 8.  Epigenetic control of cytomegalovirus latency and reactivation.

Authors:  Xue-feng Liu; Xueqiong Wang; Shixian Yan; Zheng Zhang; Michael Abecassis; Mary Hummel
Journal:  Viruses       Date:  2013-05-23       Impact factor: 5.048

9.  Murine Cytomegalovirus-induced Complement-fixing Antibodies Deposit in Murine Renal Allografts During Acute Rejection.

Authors:  Ute Saunders; Mao Li; Srinivasa R Boddeda; Sonya Maher; Jessica Ghere; Irina Kaptsan; Ravi Dhital; Victoria Velazquez; Lingling Guo; Bo Chen; Qiang Zeng; Trenton R Schoeb; Rachel Cianciolo; Masako Shimamura
Journal:  Transplantation       Date:  2021-08-01       Impact factor: 5.385

10.  Mitogen and stress activated kinases act co-operatively with CREB during the induction of human cytomegalovirus immediate-early gene expression from latency.

Authors:  Verity G Kew; Jinxiang Yuan; Jeffery Meier; Matthew B Reeves
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.